Pharmacological ascorbate induces ‘BRCAness’ and enhances the effects of Poly(ADP‑Ribose) polymerase inhibitors against BRCA1/2 wild‑type ovarian cancerYan Ma(University of Kansas Medical Center), Qi Chen(University of Kansas Medical Center)Oncology LettersJanuary 31, 202010.3892/ol.2020.11364Cited by 24SaveCiteExport RISWatch citationsRelated PapersEvaluation of curcumin-mediated photodynamic therapy on the reverse of multidrug resistance in tumor cells|RSC Advances|2020|19